Evidence map›Paper›PMID 18054200›Full record

ArticleCellular signalling2008

xCT expression reduces the early cell cycle requirement for calcium signaling.

Michele Lastro, Antonis Kourtidis, Kate Farley, Douglas S Conklin

Open access · greenAbstract read
In one paragraph

Article in Cellular signalling, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Michele LastroDepartment of Biomedical Sciences, Gen*NY*Sis Center for Excellence in Cancer Genomics, University at Albany, State University of New York, Room 210, One Discovery Drive, Rensselaer, NY 12144-3456, United States.
Antonis Kourtidis
Kate Farley
Douglas S Conklin
University at Albany, State University of New York · US

Funding

GENETIC APPROACH TO DRUG FUNCTIONR43GM059496 · NIGMS · GENETICA, INC. · PI CONKLIN, DOUGLAS S · 1999 to 1999
–
NIGMS NIH HHS NIH R43 GM59496-01NIGMS NIH HHS R43 GM059496
6 · The paper itself

Abstract

Calcium has long been recognized as an important regulator of cell cycle transitions although the mechanisms are largely unknown. A functional genomic screen has identified genes involved in the regulation of early cell cycle progression by calcium. These genes when overexpressed confer the ability to bypass the G1/S arrest induced by Ca(2+)-channel antagonists in mouse fibroblasts. Overexpression of the cystine-glutamate exchanger, xCT, had the greatest ability to evade calcium antagonist-induced cell cycle arrest. xCT carries out the rate limiting step of glutathione synthesis in many cell types and is responsible for the uptake of cystine in most human cancer cell lines. Functional analysis indicates that the cystine uptake activity of xCT overcomes the G1/S arrest induced by Ca(2+)-channel antagonists by bypassing the requirement for calcium signaling. Since cells overexpressing xCT were found to have increased levels and activity of the AP-1 transcription factor in G1, redox stimulation of AP-1 activity accounts for the observed growth of these cells in the presence of calcium channel antagonists. These results suggest that reduced calcium signaling impairs AP-1 activation and that xCT expression may directly affect cell proliferation.

Indexed as

Calcium SignalingCell CycleAmino Acid Transport System y+AnimalsCalciumCalcium Channel BlockersCell Line, TumorCell ProliferationFibroblastsG1 PhaseHumansMiceModels, BiologicalNifedipineNIH 3T3 CellsOxidation-ReductionAmino Acid Transport System y+CalciumCalcium Channel BlockersNifedipineSLC7A11 protein, humanSulfhydryl CompoundsTranscription Factor AP-1

Identifiers

PMID18054200
PMCPMC2812064
OpenAlexW2063204728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.